Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muriel Vray

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|January 24, 2012
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)Marc Bourlière, Denis Ouzan, Michel Rosenheim, et al.
Journal of Clinical Microbiology|October 18, 2013
Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spotsSeverine Mercier-Delarue, Muriel Vray, Jean Christophe Plantier, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunizationMarie-Anne Rey-Cuille, Richard Njouom, Claudine Bekondi, et al.
Journal of Medical Virology|January 19, 2006
Molecular epidemiology of hepatitis B virus in Dakar, SénégalMuriel Vray, Jean-Marc Debonne, Jean-Marie Sire, et al.
Maternal & Child Nutrition|April 10, 2024
Three-arm clinical trial of improved flour targeting intestinal microbiota (MALINEA)Muriel Vray, Laura Tondeur, Boris G Hedible, et al.
Journal of the International AIDS Society|October 15, 2009
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in SenegalAnna Canestri, Papa Salif Sow, Muriel Vray, et al.
Plos One|July 30, 2011
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral loadPapa Saliou Mbaye, Anna Sarr, Jean-Marie Sire, et al.
AIDS (London, England)|August 2, 2003
Clinically relevant interpretation of genotype for resistance to abacavirFrançoise Brun-Vézinet, Diane Descamps, Annick Ruffault, et al.
Medgenmed : Medscape General Medicine|March 4, 2008
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in SenegalAnna Canestri, Papa Salif Sow, Muriel Vray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2010
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assaysJean-Marie Sire, Muriel Vray, Mourad Merzouk, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|January 24, 2012
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)Marc Bourlière, Denis Ouzan, Michel Rosenheim, et al.
Journal of Clinical Microbiology|October 18, 2013
Higher specificity of nucleic acid sequence-based amplification isothermal technology than of real-time PCR for quantification of HIV-1 RNA on dried blood spotsSeverine Mercier-Delarue, Muriel Vray, Jean Christophe Plantier, et al.
The Pediatric Infectious Disease Journal|May 23, 2013
Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunizationMarie-Anne Rey-Cuille, Richard Njouom, Claudine Bekondi, et al.
Journal of Medical Virology|January 19, 2006
Molecular epidemiology of hepatitis B virus in Dakar, SénégalMuriel Vray, Jean-Marc Debonne, Jean-Marie Sire, et al.
Maternal & Child Nutrition|April 10, 2024
Three-arm clinical trial of improved flour targeting intestinal microbiota (MALINEA)Muriel Vray, Laura Tondeur, Boris G Hedible, et al.
Journal of the International AIDS Society|October 15, 2009
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in SenegalAnna Canestri, Papa Salif Sow, Muriel Vray, et al.
Plos One|July 30, 2011
Liver stiffness measurement and biochemical markers in Senegalese chronic hepatitis B patients with normal ALT and high viral loadPapa Saliou Mbaye, Anna Sarr, Jean-Marie Sire, et al.
AIDS (London, England)|August 2, 2003
Clinically relevant interpretation of genotype for resistance to abacavirFrançoise Brun-Vézinet, Diane Descamps, Annick Ruffault, et al.
Medgenmed : Medscape General Medicine|March 4, 2008
Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in SenegalAnna Canestri, Papa Salif Sow, Muriel Vray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2010
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assaysJean-Marie Sire, Muriel Vray, Mourad Merzouk, et al.
Pageof 10